Life Sciences
Rigid regulation, demanding clinical trials and licensing processes may have held back the digitalization of life sciences sector. However
Search results
We hope you find what you are looking for. Please let us know if we can assist you.
53 results found.
services
services
Patents & Life Sciences
We focus on safeguarding intellectual property and navigating intricate legal landscapes, ensuring that our clients remain compliant and
reference
Cross-border transfer of business and collective dismissals
We assisted Santen Pharmaceuticals in employment related matters in a large-scale cross-border transfer of business.
reference
Large-scale use of fixed-term employment contracts
We have represented Bayer in several court proceedings pending in the appeal court concerning, e.g., large scale use
reference
Easement agreement and lease negotiations
We advised Pfizer Oy in a demanding easement arrangement and lease negotiations regarding premises located in Finland.
insight
Temporary obligation to notify concentrations to the FCCA on social and health care sector
On 15 June 2017, the Council of State put forward amendments to the Competition Act concerning a wider
insight
The Finnish Government publishes proposal on patient’s freedom of choice
As a part of the major health and social services reform, the Finnish Government published on 9 May
insight
The Finnish Government publishes draft proposal on patient’s freedom of choice
As a part of the major health and social services reform, the Finnish Government published on 21 December
reference
Sale of Evondos Group
We advised Serendipity Partners and other sellers in the sale of Evondos Oy, the leading Nordic welfare technology
reference
WWL Life Sciences 2020
D&I’s Partner Johan Åkermarck has been ranked as one of the Recommended Global Leaders in the Regulatory and